Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
about
Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling.MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosisMicrobiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascitesPortal hypertension as immune mediate disease.Hepatic inflammation and fibrosis: functional links and key pathways.Potent natural products and herbal medicines for treating liver fibrosisContemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study.A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages.Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior.Overexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cellsTLR4-Dependent Secretion by Hepatic Stellate Cells of the Neutrophil-Chemoattractant CXCL1 Mediates Liver Response to Gut Microbiota.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsExosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration.MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.Regulation of wound healing and organ fibrosis by toll-like receptors.Immune dysfunction in cirrhosis.Rifaximin: beyond the traditional antibiotic activity.Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.Recent advancement of molecular mechanisms of liver fibrosis.Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Expression of Septin4 in human hepatic stellate cells LX-2 stimulated by LPS.The gut microbiome and liver cancer: mechanisms and clinical translation.Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota CompositionRifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats.Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway.Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.Isolation and time lapse microscopy of highly pure hepatic stellate cells.Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways.Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives
P2860
Q33822409-12F9978E-5728-4AE8-8390-716807A59AB0Q34323121-55AAD7DA-FC79-451C-8B19-433CCF41EC65Q34647371-25CD80DE-AE28-4A14-80FF-0AC5CDE1F5C4Q35025282-084D2D56-3CDC-4817-99D6-2E44B989123EQ35136411-FFF6C6E6-0D26-4857-A40E-2F358A457375Q35143004-A629F348-D366-45DB-A21D-E6A3E453D2FEQ35197361-FEECBAD1-12B9-4861-81DF-C862AAAAA3E3Q35213917-F5E4C10E-B54A-4698-874F-D396124322E9Q35494410-04D4373D-C6F2-4E57-92F1-F6CBA2584F9FQ35651447-97070688-86F4-4BA2-841A-C03A664D19D5Q35810550-33DC6D04-FDB7-44BD-A277-A7B2F7323CD5Q35898018-496318CC-0A96-42E2-BC7D-432B10B5CC05Q35899043-6EAED024-B689-45FD-A916-44DE83D8BB2DQ35925507-2FD91537-0F87-446F-BF88-6337A0732B8EQ35965968-49B50363-172E-4860-A7CC-F4948760F8CFQ35977675-952EEF40-0A3D-4D11-BE16-DD04ED487B8EQ36407214-AB66247F-A1DC-417B-BD50-1995A7A2AFF6Q37134499-5EC1A014-E38B-4230-BA29-234996B053D6Q38065649-D419300B-59BC-45AE-9F1F-6067B36FB95AQ38195835-735C5C63-7B5F-4D3B-B362-03CDE40175CDQ38237218-B8D6B069-AB58-4B77-A73B-BA1D198D7D95Q38413291-B5E527C3-7CBE-4DA2-9C89-D66C156F421CQ38419194-F9577590-E6A0-46D5-BE2B-2AC51F7421F2Q38446357-AF6DA895-6B87-4141-B471-1B2F35E33DC2Q38759447-638EF9B2-7654-48E4-BCE8-D919F1120480Q38902371-4D145FE8-87F8-4100-9098-1413B91CDD97Q39140170-FB425B54-109A-42EB-86F9-A84BF66547AFQ39238912-3DDEF5CC-0185-428F-9BC7-F8B230A49AEAQ39414187-487C1A51-0C9E-4B33-AB87-E998A12C8DEDQ41246828-1586369C-FCD2-4BE7-8AA3-EF89218E3644Q47118655-C5D18874-0BDB-47FE-AF73-1E1AB6405271Q49540955-8B4428C6-DCC9-4153-97E2-0E460CF418BFQ50048814-EF51727A-82D0-4A50-8447-BECE4AB507B2Q50074560-D34C5C35-EE1C-4FC7-8AF0-F3F30C70EDADQ50356537-99B54C06-8366-46A5-AEB7-3659CF08384AQ52925783-8A9EEA2E-2120-4D6C-8A41-CD7A11EBDD73Q54981313-1B117BC7-74C8-44C3-9A4D-BB0C396B77B9Q58760398-1DC14D11-C7C1-43B2-A1B7-6D3D61218E6C
P2860
Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@ast
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@en
type
label
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@ast
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@en
prefLabel
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@ast
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@en
P2093
P2860
P1476
Intestinal decontamination inh ...... ells in liver fibrosis in mice
@en
P2093
Douglas A Simonetto
Kumaravelu Jagavelu
Robert C Huebert
Vijay H Shah
Zhi-Dong Jiang
P2860
P304
P356
10.1016/J.JHEP.2011.11.013
P577
2011-12-13T00:00:00Z